Considerations for adjuvant immunotherapy in stage II melanoma: KEYNOTE-716 and beyond
Ann Transl Med
.
2023 Aug 30;11(10):368.
doi: 10.21037/atm-23-839.
Epub 2023 Mar 13.
Authors
Lanyi Nora Chen
1
,
Richard D Carvajal
2
Affiliations
1
Columbia University Medical Center, New York, NY, USA.
2
Northwell Health Cancer Institute, New Hyde Park, NY, USA.
PMID:
37675306
PMCID:
PMC10477649
DOI:
10.21037/atm-23-839
No abstract available
Keywords:
Melanoma; adjuvant therapy; immunotherapy.
Publication types
Editorial
Comment